MetaADEDB 2.0 @ LMMD
nefazodone
(DYCKFEBIOUQECE-UHFFFAOYSA-N)
Structure
SMILES
CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl.Cl
Molecular Formula:
C25H33Cl2N5O2
Molecular Weight:
506.468
Log P:
4.3568
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
55.53
CAS Number(s):
82752-99-6
Synonym(s)
1.
nefazodone
2.
Apo-Nefazodone
3.
Dutonin
4.
Lin-Nefazodone
5.
Menfazona
6.
Nefadar
7.
Rulivan
8.
Serzone
9.
nefazodone hydrochloride
External Link(s)
MeSHC051752
PubChem Compound25137870
54911
ChEBI7495
CHEMBLCHEMBL1200492
KEGGdr:D00819
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 36US FAERS
2ChromaturiaFAERS: 24US FAERS
3FatigueFAERS: 23US FAERS
4Hepatitis CFAERS: 23US FAERS
5DizzinessFAERS: 21US FAERS
6Alanine Aminotransferase IncreasedFAERS: 19US FAERS
7AnorexiaFAERS: 19US FAERS
8Aspartate Aminotransferase IncreasedFAERS: 17US FAERS
9Weight decreasedFAERS: 14US FAERS
10Abdominal PainFAERS: 13US FAERS
11Drug ineffectiveFAERS: 13US FAERS
12AnxietyFAERS: 12US FAERS
13jaundiceFAERS: 12US FAERS
14MalaiseFAERS: 11US FAERS
15ConstipationFAERS: 10US FAERS
16Visual disturbanceFAERS: 10US FAERS
17AmnesiaFAERS: 9US FAERS
18Completed SuicideFAERS: 9US FAERS
19HeadacheFAERS: 9US FAERS
20Pharmaceutical product complaintFAERS: 9US FAERS
21VomitingFAERS: 9US FAERS
22HepatitisFAERS: 8US FAERS
23PainFAERS: 8US FAERS
24SomnolenceFAERS: 8US FAERS
25AstheniaFAERS: 7US FAERS
26Drug exposure during pregnancyFAERS: 7US FAERS
27Medication ErrorFAERS: 7US FAERS
28AgitationFAERS: 6US FAERS
29Feeling abnormalFAERS: 6US FAERS
30HepatomegalyFAERS: 6US FAERS
31Sexual DysfunctionFAERS: 6US FAERS
32ArthralgiaFAERS: 5US FAERS
33Blood alkaline phosphatase increasedFAERS: 5US FAERS
34ChillsFAERS: 5US FAERS
35Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
36PregnancyFAERS: 5US FAERS
37PriapismFAERS: 5US FAERS
38Back PainFAERS: 4US FAERS
39Chest PainFAERS: 4US FAERS
40Drug toxicityFAERS: 4US FAERS
41Feeling ColdFAERS: 4US FAERS
42HepatotoxicityFAERS: 4US FAERS
43NervousnessFAERS: 4US FAERS
44TremorFAERS: 4US FAERS
45Blood glucose decreasedFAERS: 3US FAERS
46Diabetes MellitusFAERS: 3US FAERS
47Erectile dysfunctionFAERS: 3US FAERS
48Hepatic necrosisFAERS: 3US FAERS
49HypersensitivityFAERS: 3US FAERS
50Mood swingsFAERS: 3US FAERS
51Myocardial InfarctionFAERS: 3US FAERS
52OverdoseFAERS: 3US FAERS
53PalpitationsFAERS: 3US FAERS
54Pancreatic carcinomaFAERS: 3US FAERS
55PolyneuropathyFAERS: 3US FAERS
56TinnitusFAERS: 3US FAERS
57Unevaluable eventFAERS: 3US FAERS
58UrticariaFAERS: 3US FAERS
59Abdominal discomfortFAERS: 2US FAERS
60Autoimmune hepatitisFAERS: 2US FAERS
61Blood cholesterol increasedFAERS: 2US FAERS
62Blood potassium decreasedFAERS: 2US FAERS
63Burning sensationFAERS: 2US FAERS
64CholelithiasisFAERS: 2US FAERS
65CholestasisFAERS: 2US FAERS
66DeafnessFAERS: 2US FAERS
67DehydrationFAERS: 2US FAERS
68DysgeusiaFAERS: 2US FAERS
69DyspepsiaFAERS: 2US FAERS
70EczemaFAERS: 2US FAERS
71Feeling jitteryFAERS: 2US FAERS
72Food aversionFAERS: 2US FAERS
73Hepatitis AFAERS: 2US FAERS
74InfertilityFAERS: 2US FAERS
75Intentional self-injuryFAERS: 2US FAERS
76LethargyFAERS: 2US FAERS
77Mental status changesFAERS: 2US FAERS
78MyalgiaFAERS: 2US FAERS
79Night sweatsFAERS: 2US FAERS
80PruritusFAERS: 2US FAERS
81Suicide attemptFAERS: 2US FAERS
82ThrombosisFAERS: 2US FAERS
83Abdominal tendernessFAERS: 1US FAERS
84AcneFAERS: 1US FAERS
85Actinic keratosisFAERS: 1US FAERS
86Acute myocardial infarctionFAERS: 1US FAERS
87Adverse eventFAERS: 1US FAERS
88AgeusiaFAERS: 1US FAERS
89AkathisiaFAERS: 1US FAERS
90Alanine aminotransferase abnormalFAERS: 1US FAERS
91AlopeciaFAERS: 1US FAERS
92Ammonia increasedFAERS: 1US FAERS
93AmputationFAERS: 1US FAERS
94AngerFAERS: 1US FAERS
95Antibody test positiveFAERS: 1US FAERS
96AsthmaFAERS: 1US FAERS
97BlepharitisFAERS: 1US FAERS
98Blood glucose increasedFAERS: 1US FAERS
99Blood sodium decreasedFAERS: 1US FAERS
100Blood urea increasedFAERS: 1US FAERS
101BradycardiaFAERS: 1US FAERS
102BronchitisFAERS: 1US FAERS
103Candida sepsisFAERS: 1US FAERS
104Carbon Monoxide PoisoningFAERS: 1US FAERS
105CardiomegalyFAERS: 1US FAERS
106CardiotoxicityFAERS: 1US FAERS
107CataractFAERS: 1US FAERS
108Cerebrovascular accidentFAERS: 1US FAERS
109Chest discomfortFAERS: 1US FAERS
110CholecystitisFAERS: 1US FAERS
111Cognitive deteriorationFAERS: 1US FAERS
112ColitisFAERS: 1US FAERS
113Complex partial seizuresFAERS: 1US FAERS
114CryingFAERS: 1US FAERS
115CystFAERS: 1US FAERS
116Dental cariesFAERS: 1US FAERS
117Depression suicidalFAERS: 1US FAERS
118DisorientationFAERS: 1US FAERS
119DrowningFAERS: 1US FAERS
120Drug DependenceFAERS: 1US FAERS
121Drug dispensing errorFAERS: 1US FAERS
122Drug screen false positiveFAERS: 1US FAERS
123Drug withdrawal syndromeFAERS: 1US FAERS
124Duodenal UlcerFAERS: 1US FAERS
125DysuriaFAERS: 1US FAERS
126EpididymitisFAERS: 1US FAERS
127Erection increasedFAERS: 1US FAERS
128Exaggerated startle responseFAERS: 1US FAERS
129ExcitabilityFAERS: 1US FAERS
130Eye irritationFAERS: 1US FAERS
131FibromyalgiaFAERS: 1US FAERS
132Flight of ideasFAERS: 1US FAERS
133FlushingFAERS: 1US FAERS
134Genital burning sensationFAERS: 1US FAERS
135GoutFAERS: 1US FAERS
136Hepatitis C antibody positiveFAERS: 1US FAERS
137HepatoblastomaFAERS: 1US FAERS
138HirsutismFAERS: 1US FAERS
139HypersomniaFAERS: 1US FAERS
140HypertrichosisFAERS: 1US FAERS
141HypotensionFAERS: 1US FAERS
142Immature respiratory systemFAERS: 1US FAERS
143Impaired work abilityFAERS: 1US FAERS
144IncoherentFAERS: 1US FAERS
145IncontinenceFAERS: 1US FAERS
146Intervertebral Disc DegenerationFAERS: 1US FAERS
147LaryngitisFAERS: 1US FAERS
148Liver AbscessFAERS: 1US FAERS
149Liver transplant rejectionFAERS: 1US FAERS
150Lobar PneumoniaFAERS: 1US FAERS
151Malignant melanoma of sites other than skinFAERS: 1US FAERS
152Memory impairmentFAERS: 1US FAERS
153Multiple SclerosisFAERS: 1US FAERS
154Muscle RigidityFAERS: 1US FAERS
155Musculoskeletal discomfortFAERS: 1US FAERS
156MydriasisFAERS: 1US FAERS
157Ocular icterusFAERS: 1US FAERS
158OculogyrationFAERS: 1US FAERS
159Oropharyngeal swellingFAERS: 1US FAERS
160ParanoiaFAERS: 1US FAERS
161Pharmaceutical product counterfeitFAERS: 1US FAERS
162Pharyngolaryngeal PainFAERS: 1US FAERS
163Pleuritic painFAERS: 1US FAERS
164Portal triaditisFAERS: 1US FAERS
165Prothrombin level decreasedFAERS: 1US FAERS
166Rheumatoid ArthritisFAERS: 1US FAERS
167ScotomaFAERS: 1US FAERS
168SepsisFAERS: 1US FAERS
169Serotonin SyndromeFAERS: 1US FAERS
170Sinus bradycardiaFAERS: 1US FAERS
171SinusitisFAERS: 1US FAERS
172Splenic neoplasm malignancy unspecifiedFAERS: 1US FAERS
173SplenomegalyFAERS: 1US FAERS
174SyncopeFAERS: 1US FAERS
175TheftFAERS: 1US FAERS
176Therapeutic product ineffectiveFAERS: 1US FAERS
177Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
178ThirstFAERS: 1US FAERS
179Tooth LossFAERS: 1US FAERS
180TorticollisFAERS: 1US FAERS
181TrismusFAERS: 1US FAERS
182UlcerFAERS: 1US FAERS
183Urinary IncontinenceFAERS: 1US FAERS
184Urinary RetentionFAERS: 1US FAERS
185Urinary hesitationFAERS: 1US FAERS
186VertigoFAERS: 1US FAERS
187Visual ImpairmentFAERS: 1US FAERS
188White blood cell count decreasedFAERS: 1US FAERS
189Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.